PTC Therapeutics, Inc.
PTCT
$46.39
$0.380.83%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1,415.24% | 38.22% | -7.54% | -8.30% | 41.22% |
| Total Depreciation and Amortization | 6.76% | 4.29% | -7.58% | -87.33% | -31.36% |
| Total Amortization of Deferred Charges | -2.61% | 2.33% | 1.69% | -0.34% | -1.00% |
| Total Other Non-Cash Items | 590.50% | -159.55% | -58.71% | -23.20% | -27.97% |
| Change in Net Operating Assets | -215.04% | 272.04% | 187.96% | -117.06% | 179.30% |
| Cash from Operations | 2,999.96% | 61.03% | -7.75% | -200.98% | 170.56% |
| Capital Expenditure | 54.23% | -621.65% | -107.08% | 176.92% | -72.26% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -99.94% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -167.30% | 743.76% | 58.38% | 3.80% | -18.56% |
| Cash from Investing | -168.87% | 727.33% | 35.27% | 42.64% | -21.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 99.50% |
| Issuance of Common Stock | -40.50% | 4,519.72% | -87.78% | 131.03% | -16.05% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -107.53% | -- | -- |
| Cash from Financing | -64.45% | 250.17% | -107.15% | 45,544.81% | -99.91% |
| Foreign Exchange rate Adjustments | 162.33% | -201.30% | 264.68% | -155.52% | -165.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 174.16% | 298.46% | -223.90% | 327.59% | -110.65% |